Correlation Between Aerovate Therapeutics and Eneos Holdings

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Eneos Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Eneos Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Eneos Holdings ADR, you can compare the effects of market volatilities on Aerovate Therapeutics and Eneos Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Eneos Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Eneos Holdings.

Diversification Opportunities for Aerovate Therapeutics and Eneos Holdings

-0.49

Correlation Coefficient

Aerovate Therapeutics  Eneos Holdings

Very good diversification

The 3 months correlation between Aerovate and Eneos is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Eneos Holdings ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eneos Holdings ADR and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Eneos Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eneos Holdings ADR has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Eneos Holdings go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Eneos Holdings

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.53 times more return on investment than Eneos Holdings. However, Aerovate Therapeutics is 1.89 times less risky than Eneos Holdings. It trades about 0.14 of its potential returns per unit of risk. Eneos Holdings ADR is currently generating about 0.02 per unit of risk. If you would invest  191.00  in Aerovate Therapeutics on September 16, 2024 and sell it today you would earn a total of  62.00  from holding Aerovate Therapeutics or generate 32.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Eneos Holdings ADR

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Eneos Holdings ADR

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eneos Holdings ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Eneos Holdings may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Aerovate Therapeutics and Eneos Holdings

The main advantage of trading using opposite Aerovate Therapeutics and Eneos Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Eneos Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eneos Holdings will offset losses from the drop in Eneos Holdings' long position.

The idea behind Aerovate Therapeutics and Eneos Holdings ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.